Responses
Original Article
Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.